United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products

Exclusive license agreement for Treprostinil Technosphere®; $95 million in upfront and milestone payments Research agreement for additional products for additional $10 million SILVER SPRING, Md. and WESTLAKE VILLAGE, Calif., Sept. 4, 2018 -- (Hea... Biopharmaceuticals, Licensing United Therapeutics, MannKind, Treprostinil, Technosphere
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news